The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network

[1]  D. Magen,et al.  Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial , 2022, Pediatric Nephrology.

[2]  B. Hoppe,et al.  Clinical and economic impact of primary hyperoxaluria: a retrospective claims analysis , 2022, Journal of managed care & specialty pharmacy.

[3]  L. Peruzzi,et al.  Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease , 2022, Journal of Nephrology.

[4]  J. Bacchetta,et al.  The effect of lumasiran therapy for primary hyperoxaluria type 1 in small infants , 2022, Pediatric Nephrology.

[5]  Ch Lai,et al.  Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria , 2021, British journal of clinical pharmacology.

[6]  M. Kotb,et al.  Primary hyperoxaluria type 1 in children: Clinical classification, renal replacement therapy, and outcome in a single centre experience , 2021, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[7]  M. Zaniew,et al.  A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3. , 2021, Kidney international.

[8]  J. Lieske,et al.  Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study. , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  Ritu Khare,et al.  Development and evaluation of an EHR‐based computable phenotype for identification of pediatric Crohn's disease patients in a National Pediatric Learning Health System , 2020, Learning health systems.

[10]  J. Lieske,et al.  Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening. , 2019, Kidney international.

[11]  E. Salido,et al.  Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up. , 2019, Kidney international.

[12]  C. Forrest,et al.  Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data , 2019, Pediatric blood & cancer.

[13]  N. Sreeram,et al.  Subclinical myocardial disease in patients with primary hyperoxaluria and preserved left ventricular ejection fraction: a two-dimensional speckle-tracking imaging study , 2019, Pediatric Nephrology.

[14]  Rebecca A Hubbard,et al.  A Bayesian latent class approach for EHR‐based phenotyping , 2018, Statistics in medicine.

[15]  Y. Dimitrov,et al.  Paraplegia as a presentation of primary hyperoxaluria , 2018, CEN Case Reports.

[16]  I. Azam,et al.  Primary hyperoxaluria in populations of Pakistan origin: results from a literature review and two major registries , 2018, Urolithiasis.

[17]  B. Hoppe,et al.  Systematic assessment of urinary hydroxy-oxo-glutarate for diagnosis and follow-up of primary hyperoxaluria type III , 2017, Pediatric Nephrology.

[18]  M. Kotb,et al.  Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center. , 2017, Nephrologie & therapeutique.

[19]  J. Abdelmoula,et al.  Primary hyperoxaluria in infants. , 2016, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[20]  M. Al Riyami,et al.  Primary Hyperoxaluria Type 1 in 18 Children: Genotyping and Outcome , 2015, International journal of nephrology.

[21]  D. Liebeskind,et al.  Stroke in Primary Hyperoxaluria Type I , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[22]  Keith Marsolo,et al.  PEDSnet: a National Pediatric Learning Health System , 2014, J. Am. Medical Informatics Assoc..

[23]  N. Printza,et al.  Secondary perforating dermatosis in an infant with primary hyperoxaluria type I , 2014, European Journal of Dermatology.

[24]  J. Groothoff,et al.  Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  T. Gargah,et al.  Severe pneumococcal hemolytic uremic syndrome in an 8-month-old girl. , 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[26]  E. Salido,et al.  Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  F. Emma,et al.  Combined split liver and kidney transplantation in a three‐year‐old child with primary hyperoxaluria type 1 and complete thrombosis of the inferior vena cava , 2011, Pediatric transplantation.

[28]  B. Hoppe,et al.  The primary hyperoxalurias. , 2009, Kidney international.

[29]  F. Fassari,et al.  Oxalosis in primary hyperoxaluria in infancy , 2009, Skeletal Radiology.

[30]  M. Fishbein,et al.  Atherosclerotic oxalosis in coronary arteries. , 2008, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[31]  B. Hoppe,et al.  Is there a genotype-phenotype correlation in primary hyperoxaluria type 1? , 2006, Kidney international.

[32]  E. Bergstralh,et al.  International Registry for Primary Hyperoxaluria , 2005, American Journal of Nephrology.

[33]  B. Hoppe,et al.  A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria , 2003, Pediatric Nephrology.

[34]  M. Kemper,et al.  Nephrocalcinosis in a patient with primary hyperoxaluria type 2 , 1996, Pediatric Nephrology.

[35]  A. Kamoun,et al.  End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome , 1996, Pediatric Nephrology.

[36]  R. Rodby,et al.  Rapid Reversal of Bone Scan Abnormalities in a Patient With Type 1 Primary Hyperoxaluria and Oxalosis , 1994, Clinical nuclear medicine.

[37]  N. Rhuma,et al.  Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital. , 2018, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[38]  F. Kaskel,et al.  Primary hyperoxaluria: spectrum of clinical and imaging findings , 2016, Pediatric Radiology.